First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
42.76
+0.54 (1.28%)
Aug 25, 2026, 4:00 PM EDT - Market closed
FTXH Holdings Information
FTXH is an equity ETF with a total of 50 individual holdings. The top holdings are Eli Lilly and Company stock at 7.48%, AbbVie at 7.19%, Merck & Co. at 7.03%, Johnson & Johnson at 7.03%, and Bristol-Myers Squibb Company at 6.82%.
Total Holdings
50
Top 10 Percentage
52.93%
Asset Class
Equity
ETF Category
Health
Assets
1.06B
PE Ratio
22.51
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 7.48% |
| 2 | ABBV | AbbVie Inc. | 7.19% |
| 3 | MRK | Merck & Co., Inc. | 7.03% |
| 4 | JNJ | Johnson & Johnson | 7.03% |
| 5 | BMY | Bristol-Myers Squibb Company | 6.82% |
| 6 | BIIB | Biogen Inc. | 3.57% |
| 7 | AMGN | Amgen Inc. | 3.54% |
| 8 | VTRS | Viatris Inc. | 3.49% |
| 9 | VRTX | Vertex Pharmaceuticals Incorporated | 3.43% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.35% |
| 11 | CAH | Cardinal Health, Inc. | 3.31% |
| 12 | PFE | Pfizer Inc. | 3.17% |
| 13 | GILD | Gilead Sciences, Inc. | 3.10% |
| 14 | UTHR | United Therapeutics Corporation | 2.47% |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 2.47% |
| 16 | INCY | Incyte Corporation | 2.46% |
| 17 | ILMN | Illumina, Inc. | 2.01% |
| 18 | ZTS | Zoetis Inc. | 1.82% |
| 19 | CRL | Charles River Laboratories International, Inc. | 1.73% |
| 20 | EXEL | Exelixis, Inc. | 1.59% |
| 21 | HALO | Halozyme Therapeutics, Inc. | 1.53% |
| 22 | MEDP | Medpace Holdings, Inc. | 1.48% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.23% |
| 24 | ALKS | Alkermes plc | 1.21% |
| 25 | NBIX | Neurocrine Biosciences, Inc. | 1.18% |
As of Aug 18, 2026